We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01377701
Recruitment Status : Unknown
Verified June 2011 by Huashan Hospital.
Recruitment status was:  Recruiting
First Posted : June 21, 2011
Last Update Posted : June 21, 2011
Information provided by:
Huashan Hospital

Brief Summary:
Pituitary adenomas can cause compression of optic nerves and chiasm, which will lead to damage of vision. This study aims to evaluate the predictive factors for recovery of vision in patients with pituitary adenomas following trans-sphenoidal surgery.

Condition or disease
Pituitary Adenomas

Study Type : Observational
Estimated Enrollment : 150 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor
Study Start Date : June 2011
Estimated Primary Completion Date : December 2012
Estimated Study Completion Date : December 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with pituitary adenomas at Huashan Hospital will be screened. Patients with loss of visual field and receive trans-sphenoidal surgery will be included.

Inclusion Criteria:

  • >18 years old
  • patients with pituitary adenomas, loss of visual field
  • patients receive trans-sphenoidal surgery

Exclusion Criteria:

  • visual damage caused by other diseases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01377701

Contact: Yao Zhao, M.D. 86-13916872553 zhaoyaohs@vip.sina.com

Huashan Hospital Recruiting
Shanghai, China, 200040
Contact: Yao Zhao, M.D.       zhaoyaohs@vip.sina.com   
Principal Investigator: Yao Zhao, M.D.         
Sponsors and Collaborators
Huashan Hospital
Principal Investigator: Yao Zhao, M.D. Huashan Hospital

Responsible Party: Yao Zhao, Huashan Hospital
ClinicalTrials.gov Identifier: NCT01377701     History of Changes
Other Study ID Numbers: KY2010-259
First Posted: June 21, 2011    Key Record Dates
Last Update Posted: June 21, 2011
Last Verified: June 2011

Keywords provided by Huashan Hospital:
pituitary adenomas
recovery of vision
trans-sphenoidal surgery

Additional relevant MeSH terms:
Pituitary Diseases
Pituitary Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Hypothalamic Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Hypothalamic Neoplasms
Supratentorial Neoplasms
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms